JP2022515820A5 - - Google Patents
Info
- Publication number
- JP2022515820A5 JP2022515820A5 JP2021537704A JP2021537704A JP2022515820A5 JP 2022515820 A5 JP2022515820 A5 JP 2022515820A5 JP 2021537704 A JP2021537704 A JP 2021537704A JP 2021537704 A JP2021537704 A JP 2021537704A JP 2022515820 A5 JP2022515820 A5 JP 2022515820A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2018146029 | 2018-12-25 | ||
| RU2018146029A RU2711871C3 (ru) | 2018-12-25 | Моноклональные антитела, которые специфически связываются с участком бета цепи семейства TRBV-9 Т-клеточного рецептора человека, и способы их применения | |
| PCT/RU2019/050257 WO2020139171A1 (ru) | 2018-12-25 | 2019-12-24 | Моноклональные антитела, специфически связывающиеся с trbv-9 человека |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2022515820A JP2022515820A (ja) | 2022-02-22 |
| JP2022515820A5 true JP2022515820A5 (https=) | 2023-01-10 |
| JPWO2020139171A5 JPWO2020139171A5 (https=) | 2023-01-10 |
| JP7507160B2 JP7507160B2 (ja) | 2024-06-27 |
Family
ID=69184146
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021537704A Active JP7507160B2 (ja) | 2018-12-25 | 2019-12-24 | ヒトｔｒｂｖ９に特異的に結合するモノクローナル抗体 |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US12297269B2 (https=) |
| EP (2) | EP4721817A2 (https=) |
| JP (1) | JP7507160B2 (https=) |
| KR (1) | KR20210118843A (https=) |
| CN (1) | CN113692412B (https=) |
| AR (1) | AR117735A1 (https=) |
| AU (1) | AU2019416787A1 (https=) |
| BR (1) | BR112021012550A2 (https=) |
| CA (1) | CA3124800A1 (https=) |
| CL (1) | CL2021001704A1 (https=) |
| CO (1) | CO2021008204A2 (https=) |
| CR (1) | CR20210353A (https=) |
| EA (1) | EA202100199A1 (https=) |
| EC (1) | ECSP21046332A (https=) |
| IL (1) | IL284367A (https=) |
| JO (1) | JOP20210168B1 (https=) |
| MA (1) | MA53688B1 (https=) |
| MX (1) | MX2021007718A (https=) |
| MY (1) | MY206214A (https=) |
| NZ (1) | NZ778430A (https=) |
| PE (1) | PE20211792A1 (https=) |
| PH (1) | PH12021551535A1 (https=) |
| SG (1) | SG11202106974SA (https=) |
| WO (1) | WO2020139171A1 (https=) |
| ZA (1) | ZA202104356B (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2694412C9 (ru) | 2017-12-25 | 2019-09-18 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Российский национальный исследовательский медицинский университет им. Н.И. Пирогова" Министерства здравоохранения Российской Федерации (ФГБОУ ВО РНИМУ им. Н.И. Пирогова Минздрава России) | Моноклональные антитела и способы их применения |
| EP3737692A4 (en) | 2018-01-09 | 2021-09-29 | Elstar Therapeutics, Inc. | CALRETICULIN AND MODIFIED T-LYMPHOCYTES BINDING CONSTRUCTIONS FOR THE TREATMENT OF DISEASES |
| US12152073B2 (en) | 2018-03-14 | 2024-11-26 | Marengo Therapeutics, Inc. | Multifunctional molecules that bind to calreticulin and uses thereof |
| EP3818083A2 (en) | 2018-07-03 | 2021-05-12 | Elstar Therapeutics, Inc. | Anti-tcr antibody molecules and uses thereof |
| AU2020224681A1 (en) | 2019-02-21 | 2021-09-16 | Marengo Therapeutics, Inc. | Antibody molecules that bind to NKp30 and uses thereof |
| JP7710373B2 (ja) | 2019-02-21 | 2025-07-18 | マレンゴ・セラピューティクス，インコーポレーテッド | Ｔ細胞関連のがん細胞に結合する多機能性分子およびその使用 |
| CN116234829A (zh) | 2020-01-03 | 2023-06-06 | 马伦戈治疗公司 | 抗tcr抗体分子及其用途 |
| WO2025075529A1 (en) * | 2023-10-04 | 2025-04-10 | Joint Stock Company "Biocad" | Antibody binds to trbv5-1 segment of human tor domain |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5766947A (en) | 1988-12-14 | 1998-06-16 | Astra Ab | Monoclonal antibodies reactive with an epitope of a Vβ3.1 variable region of a T cell receptor |
| US5223426A (en) | 1988-12-15 | 1993-06-29 | T Cell Sciences, Inc. | Monoclonal antibodies reactive with defined regions of the t-cell antigen receptor |
| MXPA05000511A (es) * | 2001-07-12 | 2005-09-30 | Jefferson Foote | Anticuepros super humanizados. |
| CN102459643B (zh) | 2009-06-25 | 2016-06-01 | 弗雷德哈钦森癌症研究中心 | 检测获得性免疫的方法 |
| WO2012008397A1 (ja) | 2010-07-12 | 2012-01-19 | 第一三共株式会社 | 抗ｅｐｈａ２抗体及びその用途 |
| US20130273089A1 (en) * | 2011-11-03 | 2013-10-17 | Tolera Therapeutics, Inc. | Antibody and methods for selective inhibition of t-cell responses |
| PL2991683T3 (pl) | 2013-05-02 | 2020-03-31 | Glykos Finland Oy | Koniugaty glikoproteiny lub glikanu z toksycznym ładunkiem |
| EP3202784A1 (en) * | 2016-02-08 | 2017-08-09 | Polybiocept AB | T-cell receptor sequences for active immunotherapy |
| EP3472208B9 (en) | 2016-06-17 | 2023-10-04 | Medigene Immunotherapies GmbH | T cell receptors and uses thereof |
| EP3538113A4 (en) | 2016-11-14 | 2020-08-19 | Fred Hutchinson Cancer Research Center | HIGH AFFINITY MERKEL CELL POLYOMAVIRUS T ANTIGEN SPECIFIC TCRs AND THEIR USES |
| JP7162607B2 (ja) * | 2017-02-27 | 2022-10-28 | 中外製薬株式会社 | 抗ｈｌａ－ｄｑ２．５／８抗体およびセリアック病の治療のためのその使用 |
| CN107502671B (zh) * | 2017-10-12 | 2020-05-05 | 中国医学科学院肿瘤医院 | 利用trbv家族成员预测曲妥珠单抗新辅助治疗乳腺癌患者疗效试剂盒及其应用 |
| RU2694412C9 (ru) | 2017-12-25 | 2019-09-18 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Российский национальный исследовательский медицинский университет им. Н.И. Пирогова" Министерства здравоохранения Российской Федерации (ФГБОУ ВО РНИМУ им. Н.И. Пирогова Минздрава России) | Моноклональные антитела и способы их применения |
-
2019
- 2019-12-23 AR ARP190103841A patent/AR117735A1/es unknown
- 2019-12-24 EP EP26157540.1A patent/EP4721817A2/en active Pending
- 2019-12-24 WO PCT/RU2019/050257 patent/WO2020139171A1/ru not_active Ceased
- 2019-12-24 MA MA53688A patent/MA53688B1/fr unknown
- 2019-12-24 MY MYPI2021003582A patent/MY206214A/en unknown
- 2019-12-24 MX MX2021007718A patent/MX2021007718A/es unknown
- 2019-12-24 CR CR20210353A patent/CR20210353A/es unknown
- 2019-12-24 AU AU2019416787A patent/AU2019416787A1/en active Pending
- 2019-12-24 NZ NZ778430A patent/NZ778430A/en unknown
- 2019-12-24 EP EP19904442.1A patent/EP3904387B1/en active Active
- 2019-12-24 EA EA202100199A patent/EA202100199A1/ru unknown
- 2019-12-24 CA CA3124800A patent/CA3124800A1/en active Pending
- 2019-12-24 PE PE2021001079A patent/PE20211792A1/es unknown
- 2019-12-24 BR BR112021012550-7A patent/BR112021012550A2/pt unknown
- 2019-12-24 KR KR1020217023567A patent/KR20210118843A/ko active Pending
- 2019-12-24 CN CN201980092914.6A patent/CN113692412B/zh active Active
- 2019-12-24 SG SG11202106974SA patent/SG11202106974SA/en unknown
- 2019-12-24 US US17/417,570 patent/US12297269B2/en active Active
- 2019-12-24 JP JP2021537704A patent/JP7507160B2/ja active Active
-
2021
- 2021-06-23 CO CONC2021/0008204A patent/CO2021008204A2/es unknown
- 2021-06-24 EC ECSENADI202146332A patent/ECSP21046332A/es unknown
- 2021-06-24 JO JOJO/P/2021/0168A patent/JOP20210168B1/ar active
- 2021-06-24 IL IL284367A patent/IL284367A/en unknown
- 2021-06-24 CL CL2021001704A patent/CL2021001704A1/es unknown
- 2021-06-24 ZA ZA2021/04356A patent/ZA202104356B/en unknown
- 2021-06-25 PH PH12021551535A patent/PH12021551535A1/en unknown